Department of Neurology, Dae-Dong Hospital, Busan, Korea.
J Korean Med Sci. 2009 Dec;24(6):1038-44. doi: 10.3346/jkms.2009.24.6.1038. Epub 2009 Nov 9.
Myotonia congenita (MC) is a form of nondystrophic myotonia caused by a mutation of CLCN1, which encodes human skeletal muscle chloride channel (CLC-1). We performed sequence analysis of all coding regions of CLCN1 in patients clinically diagnosed with MC, and identified 10 unrelated Korean patients harboring mutations. Detailed clinical analysis was performed in these patients to identify their clinical characteristics in relation to their genotypes. The CLCN1 mutational analyses revealed nine different point mutations. Of these, six (p.M128I, p.S189C, p.M373L, p.P480S, p.G523D, and p.M609K) were novel and could be unique among Koreans. While some features including predominant lower extremity involvement and normal to slightly elevated creatine kinase levels were consistently observed, general clinical features were highly variable in terms of age of onset, clinical severity, aggravating factors, and response to treatment. Our study is the first systematic study of MC in Korea, and shows its expanding clinical and genetic spectrums.
先天性肌强直症(MC)是一种非营养不良性肌强直,由 CLCN1 基因突变引起,该基因编码人类骨骼肌氯离子通道(CLC-1)。我们对临床诊断为 MC 的患者的 CLCN1 所有编码区进行了序列分析,发现了 10 名无亲缘关系的韩国患者携带突变。对这些患者进行了详细的临床分析,以确定其基因型与临床特征的关系。CLCN1 突变分析显示了 9 种不同的点突变。其中 6 种(p.M128I、p.S189C、p.M373L、p.P480S、p.G523D 和 p.M609K)是新的,可能在韩国人中是独特的。虽然一些特征包括主要的下肢受累和正常或轻度升高的肌酸激酶水平持续观察到,但发病年龄、临床严重程度、加重因素和治疗反应等方面的一般临床特征高度可变。我们的研究是韩国首例对 MC 的系统研究,显示了其不断扩大的临床和遗传谱。